Germin8 Ventures
VC Fund
Chicago, United States
Germin8 Ventures is a multi-stage, strategically-oriented venture capital firm investing in disruptive Food & AgTech companies across the value chain, in various stages, globally. It is a group of like-minded industry veterans and sophisticated investors providing investment and strategic resources to transformative Food & AgricultureTechnology companies that are addressing major demand trends and improving the global food system through disruptive technologies and solutions.
- Total investments:
- 28
- Last investment:
- Lead investor:
- 14%
- Fund size:
- $20M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Germin8 Ventures invests in
Stages Germin8 Ventures invests in
Countries Germin8 Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $4M–$27M
- Series A
- $9M–$48M
- Series B
- $6.3M–$75M
Investment Focus
Industry
- Agriculture 7 (25%)
- AgTech 5 (18%)
- Biotechnology 4 (14%)
- Farming 3 (11%)
- Software 3 (11%)
Stage
- Series A 5 (18%)
- Series B 5 (18%)
- Seed 2 (7%)
- Funding Round 2 (7%)
- Series C 1 (4%)
Country
- United States 8 (29%)
- Israel 2 (7%)
- Australia 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ashlie Burkart
CSO
|
CSO | Total investments: 2 | Find email | |
Michael Lavin
Managing Partner
|
Managing Partner | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Kanvas Biosciences
|
Kanvas Biosciences developed cutting-edge imaging technology for microbial detection, providing unmatched speed, breadth, and adaptability. Kanvas aims to transform microbial research and infectious disease diagnostics through innovative imaging technology of the next generation. | $48M / Series A / May 05, 2026 | |
Matterworks
|
Matterworks is a biotech startup that combines metabolomics with AI to simulate the metabolic environment. The startup is enabling real-time insights into cellular biology to accelerate therapeutic research, development, and manufacturing with an AI-driven cloud platform for metabolomics.Matterworks was founded by Mimoun Cadosch Delmar and JackGeremia in 2019. | Series A / Jun 03, 2025 | |
Wheeler Bio
|
Wheeler Bio is a new biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact. Through parallel integration with pre-clinical discovery, Wheeler is democratizing access to comprehensive discovery-to-IND programs with its rapid, high-quality biomanufacturing and portable CMC platform. | $35M / Series A / Mar 20, 2025 | |
Avalo
|
Avalo is a plant biology company that harnesses interpretable machine learning, genomic discovery, and evolutionary theory to rapidly design new crops for the future of agriculture. Their process uses AI-assisted plant breeding, so all products are non-GMO and support the natural diversity of the world around us. The technological core of Avalo isa discovery engine that can identify the genetic underpinnings of complex traits with minimal training. In turn, these findings are leveraged into high-precision, low-cost simulations and forecasts. Even in understudied crops, Avalo can reduce the time that it takes to produce new crops by years and reduce the cost by an order of magnitude. | $11M / Series A / Mar 06, 2025 | |
|
Kanvas Biosciences
|
Kanvas Biosciences developed cutting-edge imaging technology for microbial detection, providing unmatched speed, breadth, and adaptability. Kanvas aims to transform microbial research and infectious disease diagnostics through innovative imaging technology of the next generation. | $12.5M / Series A / Jul 01, 2024 | |
|
Avalo
|
Avalo is a plant biology company that harnesses interpretable machine learning, genomic discovery, and evolutionary theory to rapidly design new crops for the future of agriculture. Their process uses AI-assisted plant breeding, so all products are non-GMO and support the natural diversity of the world around us. The technological core of Avalo isa discovery engine that can identify the genetic underpinnings of complex traits with minimal training. In turn, these findings are leveraged into high-precision, low-cost simulations and forecasts. Even in understudied crops, Avalo can reduce the time that it takes to produce new crops by years and reduce the cost by an order of magnitude. | Series A / May 21, 2024 | |
AgriWebb
|
AgriWebb is a software company focused on the livestock production industry. Its products enable simplified on-farm data collection and analysis to improve management efficiency, decision-making, benchmarking, and transparency while integrating through horizontal and vertical supply chains. AgriWebb’s founders come from 5 generations of livestockproduction and aim to transform the livestock industry through data-driven decision-making built from intuitive on-farm data recording. | $7.3M / Venture - Series Unknown / May 06, 2024 | |
Bushel
|
Bushel is an independently owned software company and leading provider of software technology solutions for growers, grain buyers, ag retailers, protein producers and food companies, headquartered in Fargo, N.D. Since launching in 2017, Bushel’s platform has grown rapidly, now powering nearly 2,000 grain facilities across the U.S. and Canada withreal-time business information for their producers. Bushel’s platform now reaches 40% of grain origination in the United States, resulting in inarguably the largest technology network effect among growers and grain buyers in the U.S. today. $22 billion of grain is contracted annually within Bushel’s ecosystem. Bushel’s product suite includes its flagship mobile app, websites, trading tools, market feeds, API services and a custom software division focused on agriculture. Bushel has been focused on building software since the company was founded in 2011. Data privacy is a cornerstone of Bushel’s philosophy. | $26M / Jul 13, 2023 | |
Andes
|
Andes empowers microbes to enable positive action against climate change. | $15M / Series A / Mar 16, 2023 | |
|
AgriWebb
|
AgriWebb is a software company focused on the livestock production industry. Its products enable simplified on-farm data collection and analysis to improve management efficiency, decision-making, benchmarking, and transparency while integrating through horizontal and vertical supply chains. AgriWebb’s founders come from 5 generations of livestockproduction and aim to transform the livestock industry through data-driven decision-making built from intuitive on-farm data recording. | $6.3M / Series B / Oct 10, 2022 | |
| See all 28 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Germin8 Ventures invest in?
Germin8 Ventures invests primarily in Agriculture, AgTech and Biotechnology startups, most often at Series A and Series B stage. Most of the 28 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Germin8 Ventures's check size?
Germin8 Ventures typically joins rounds of $4M–$27M at Seed, $9M–$48M at Series A and $6.3M–$75M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Germin8 Ventures participates in.
How do I contact Germin8 Ventures?
Public channels for Germin8 Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Germin8 Ventures?
The team at Germin8 Ventures includes Ashlie Burkart (CSO) and Michael Lavin (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
